Global and United States Precision Oncology Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global and United States Precision Oncology Market Report & Forecast 2024-2034
Precision oncology is a field of medicine that uses genetic information to adapt cancer treatment to an individual’s specific tumor and biology. It is also known as personalized medicine or precision medicine. Precision oncology identifies the unique genetic mutations and other molecular characteristics of a patient’s tumor, and then uses that information to choose the most effective treatment. This approach takes into account the genetic differences between tumors and the genetic variations among individuals and allows for targeted and effective treatment options. Precision oncology techniques include genomic profiling, which analyzes the genetic makeup of a tumor, and liquid biopsies, which detect tumor DNA in the bloodstream. This information can be used to match patients with targeted therapies that are designed to specifically target the molecular abnormalities in their tumor.
Market Analysis and InsightsGlobal and United States Precision Oncology Market
This report focuses on global and United States Precision Oncology market, also covers the segmentation data of other regions in regional level and county level.
The global Precision Oncology revenue was US$ 95500 million in 2022 and is forecast to a readjusted size of US$ 184490 million by 2033 with a CAGR of 9.8% during the review period (2023-2033).
Precision oncology has led to significant advances in cancer treatment, particularly in the treatment of rare and hard-to-treat cancers. It has helped reduce the side effects of cancer treatment by minimizing the use of chemotherapy and other treatments that may not be effective for a particular patient’s tumor.
Global Precision Oncology Scope and Market Size
Precision Oncology market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Precision Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Precision Oncology market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
Acrivon Therapeutics
Bio-Serv
Exact Sciences Corporation
Illumina, Inc.
Invitae Corporation
Laboratory Corporation of America
QIAGEN
Rain Oncology
Relay Therapeutics
Strata Oncology, Inc.
Thermo Fisher Scientific Inc.
Variantyx, Inc.
Segment by Type
Diagnostics
Therapeutics
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Healthcare Data Companies
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Precision Oncology definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Precision Oncology companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Precision Oncology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Precision Oncology revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Market Analysis and InsightsGlobal and United States Precision Oncology Market
This report focuses on global and United States Precision Oncology market, also covers the segmentation data of other regions in regional level and county level.
The global Precision Oncology revenue was US$ 95500 million in 2022 and is forecast to a readjusted size of US$ 184490 million by 2033 with a CAGR of 9.8% during the review period (2023-2033).
Precision oncology has led to significant advances in cancer treatment, particularly in the treatment of rare and hard-to-treat cancers. It has helped reduce the side effects of cancer treatment by minimizing the use of chemotherapy and other treatments that may not be effective for a particular patient’s tumor.
Global Precision Oncology Scope and Market Size
Precision Oncology market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Precision Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Precision Oncology market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
By Company
Acrivon Therapeutics
Bio-Serv
Exact Sciences Corporation
Illumina, Inc.
Invitae Corporation
Laboratory Corporation of America
QIAGEN
Rain Oncology
Relay Therapeutics
Strata Oncology, Inc.
Thermo Fisher Scientific Inc.
Variantyx, Inc.
Segment by Type
Diagnostics
Therapeutics
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Healthcare Data Companies
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Precision Oncology definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Precision Oncology companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Precision Oncology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Precision Oncology revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices